Rate cuts aren’t just good for tech stocks. Lower rates mean more investors will also take a chance on higher-risk cryptos. Here’s the opportunity that’s just getting started…
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
The Line Goes Up (the Creek without a paddle)
In a bubble, don’t fight the current, but always have an exit plan.
Cheat on Your Bank
No love lost for the Big Four
AI: Productivity Boom or Employment Bust?
When AI Becomes ‘Corporate Ozempic’
OpenAI’s Prisoner Dilemma
Today, it’s optional Orb scans for crypto rewards. Tomorrow, could it be mandatory scans for jobs, benefits, or even voting?
Imugene Gains Ethics Approval and Receives 5% Share Bump
Imugene has now crossed ethics approval off is list, and the way is now clear for clinical trials to begin in Australia.
